Author

Robert Power

Mater Misericordiae University Hospital - Cited by 161 - cancer genetics - gastrointestinal cancers - tumour immunology

Biography

He is affiliated to The Commonwealth Scientific and Industrial Research Organisation, Australia. He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals.
Title
Cited by
Year
Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity
NE Donlon, R Power, C Hayes, JV Reynolds, J LysaghtCancer Letters 502, 84-96, 2021202
70
2021
The Cancer-Immune Set Point in Oesophageal Cancer
R Power, MA Lowery, JV Reynolds, MR DunneFrontiers in Oncology 10, 891, 2020202
18
2020
Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines
NE Donlon, A Sheppard, M Davern, F O’Connell, JJ Phelan, R Power, ...Cancers 12 (11), 3356, 2020202
15
2020
The tumour immune microenvironment in oesophageal cancer
M Davern, NE Donlon, R Power, C Hayes, R King, MR Dunne, ...British Journal of Cancer 125 (4), 479-494, 2021202
14
2021
FLOT-regimen Chemotherapy and Transthoracic en bloc Resection for Esophageal and Junctional Adenocarcinoma
NE Donlon, A Kammili, R Roopnarinesingh, M Davern, R Power, S King, ...Annals of surgery 274 (5), 814-820, 2021202
12
2021
Radiation and Immunotherapy in Upper Gastrointestinal Cancers: The Current State of Play
NE Donlon, R Power, C Hayes, M Davern, JV Reynolds, J LysaghtInternational Journal of Molecular Sciences 22 (3), 71, 2021202
10
2021
Management of chyle leaks following esophageal resection: a systematic review
R Power, P Smyth, NE Donlon, T Nugent, CL Donohoe, JV ReynoldsDiseases of the Esophagus 34 (11), doab012, 2021202
9
2021
Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants
R Power, C Leavy, C Nolan, N White, R Clarke, KA Cadoo, DJ Gallagher, ...Familial Cancer 20, 97-101, 2021202
4
2021
The Immune Response to Major Gastrointestinal Cancer Surgery and Potential Implications for Adjuvant Immunotherapy
NE Donlon, M Davern, C Hayes, R Power, AD Sheppard, CL Donohoe, ...Critical Reviews in Oncology/Hematology, 10729, 2022202
3
2022
The prognostic value of the lymph node in oesophageal adenocarcinoma; incorporating clinicopathological and immunological profiling
NE Donlon, M Davern, A Sheppard, R Power, F O’Connell, AB Heeran, ...Cancers 13 (16), 4005, 010
2
2021
HPV vaccination among seropositive, DNA negative cohorts: a systematic review & meta-analysis
C Mac Eochagain, R Power, I Parker, D BrennanJournal of Gynecologic Oncology 33 (3), 2022202
1
2022
Embolization or disruption of thoracic duct and cisterna chyli leaks post oesophageal cancer surgery should be first line management for ECCG-defined type III chyle fistulae
NE Donlon, TS Nugent, R Power, W Butt, A Kamaludin, S Dolan, ...Irish Journal of Medical Science (97-) 90, -6, 20220
1
2021